CLINICAL_TRIALS
trial_result
· 2025-12-02
Clinical Trial Update: POLARx™ Cardiac Cryoablation System Post Market Clinical Study (POLAR SMART)
Summary
A post-market clinical study of the POLARx Cardiac Cryoablation System in paroxysmal atrial fibrillation has completed, with results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Boston Scientific Corporation | Conditions: Paroxysmal Atrial Fibrillation | Status: COMPLETED | Results posted: 2025-12-02